Abstract 3345
Background
Patients with advanced end stage cancer have < 1% chance of spontaneous circulation following cardiopulmonary resuscitation (CPR). Effective communication in a timely manner is best practice to ensure DNACPR (Do not attempt cardiopulmonary resuscitation) decisions are implemented correctly, well understood by patients/relatives and to avoid unnecessary CPR. Previous audit data at LRI and clinician experience indicated that oncology inpatients were having significant delays in DNACPR discussions. In many cases DNACPR decisions were occurring in emergency clinical situations by out of hours on-call medical staff.
Methods
We identified unwell (early warning score >5) oncology inpatients admitted to LRI. Using a data collection tool, we primarily identified the proportion of patients who had a DNACPR decision. Furthermore, we analysed timeliness of DNACPR decisions, involvement of patients’ own oncology team and documentation of prognosis/escalation plans. Liaising with healthcare professionals from oncology & palliative care we formulated ideas to improve outcomes. Enhancing communication between permanent ward staff (nurses & junior doctors) and senior decision makers (oncology registrars & consultants) was vital to improve outcomes. We therefore empowered junior doctors/nursing staff to identify patients who needed DNACPR discussions using a proforma tool utilising board round meetings as a platform. Data was then analysed to compare outcomes.
Results
Qualitative data showed improved confidence for junior doctors in identifying & communicating DNACPR discussions.Table:
1598P
Before Intervention | After Intervention | |
---|---|---|
DNACPR discussed by own team | 11% | 54% |
DNACPR discussed by oncology team | 29% | 92% |
DNACPR discussed in daytime | 24% | 77% |
Mean time to implement DNACPR | 4 days | 2.5 days |
DNACPR implemented and patient discharged home | 5% | 54% |
DNACPR not implemented in eligible patient – died following CPR | 44% | 12% |
Documentation of escalation plan | 30% | 85% |
Documentation of prognosis | 25% | 54% |
Conclusions
Empowering junior doctors and simple departmental changes lead to a significant improvement in communicating and implementing DNACPR decisions. We therefore significantly reduced unnecessary CPR attempts and subsequently improved communication and documentation of escalation plans and prognosis. We believe our model can be implemented in other oncology centres and look forward to discussing this further.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
National Health Service, UK.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1735 - mTOR inhibition in the treatment of resistant breast cancer
Presenter: María Rodriguez
Session: Poster Display session 1
Resources:
Abstract
6068 - Study of Photodynamic therapy in vitro
Presenter: Irene Jiménez Munguía
Session: Poster Display session 1
Resources:
Abstract
3011 - The potential of neratinib plus dasatinib in overcoming and preventing neratinib resistance in HER2-positive breast cancer models
Presenter: Neil Conlon
Session: Poster Display session 1
Resources:
Abstract
2644 - Novel HDACi, MHY446, induces apoptosis via regulation of mitochondria-endoplasmic reticulum interaction in HCT116 human colorectal cancer cells
Presenter: Nam Deuk Kim
Session: Poster Display session 1
Resources:
Abstract
3085 - Dual inhibition of TGF-β and AXL as a novel treatment for colorectal cancer
Presenter: Davide Ciardiello
Session: Poster Display session 1
Resources:
Abstract
1314 - PARP inhibition enhances cisplatin sensitivity in cervical cancer by modulating β-catenin signaling
Presenter: Minakshi Mann
Session: Poster Display session 1
Resources:
Abstract
2417 - Synergistic effect of DSF combined treatment with cisplatin in atypical teratoid/rhabdoid tumors (AT/RT)
Presenter: Seung Ah Choi
Session: Poster Display session 1
Resources:
Abstract
1149 - Reactive oxygen species induced by OSU-A9 inhibit the growth of duodenal cancer and gastric cancer cells through dephosphorylating intranuclear pyruvate kinase muscle isozyme M2
Presenter: Li-Yuan Bai
Session: Poster Display session 1
Resources:
Abstract
1862 - New therapy for intrahepatic cholangiocarcinoma targeted to cancer associated fibroblasts
Presenter: Takahiro Yamanaka
Session: Poster Display session 1
Resources:
Abstract
782 - Macrophage-cancer cell fusion is mediated by Phosphatidylserine-CD36 receptor interaction and induced by ionizing radiation
Presenter: Ivan Shabo
Session: Poster Display session 1
Resources:
Abstract